MedPath

Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer

Active, not recruiting
Conditions
Pancreatic Cancer
Interventions
Other: Oral and Fecal Sample Collection
Registration Number
NCT05689138
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

Pancreatic cancer (PCA) is a leading death-related cancer. There is an urgent need for accurate, noninvasive diagnostic options in the early detection of pancreatic cancer (PCA), since delayed diagnosis increases the risk of metastasis and recurrence. In this study, by analyzing gut and fecal microbial data among the pancreatic versus healthy populations, we aim to establish an early detection tool to improve PCA detection, and to explore potential diagnostic biomarkers.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria

PCA Newly diagnosed pancreatic cancer patients; No symptoms of jaundice; Did not yet receive any treatment

NC Individuals who were undergoing routine screenings or physical examination

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NCOral and Fecal Sample Collectionnormal control
PCAOral and Fecal Sample Collectionpancreatic cancer patients
Primary Outcome Measures
NameTimeMethod
microbial features by 16s rRNA sequencingwithin 180 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PUMCH

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath